Harvoni is made up of two separate drugs, ledipasvir and sofosbuvir. Each of these drugs block proteins that enable hepatitis C to grow. Ledipasvir blocks NS5A, a protein that plays a key role in Hepatitis C RNA replication. Sofosbuvir blocks NS5B, an RNA polymerase that also plays a role in replication the virus.